Anti-GITR antibodies and methods of use thereof Grant US-11897962-B2 United States of America 13 Feb 2024
Anti-CD25 for tumour specific cell depletion Grant US-11873341-B2 United States of America 16 Jan 2024
Anti-CD25 for tumour specific cell depletion Grant US-11851494-B2 United States of America 26 Dec 2023
USES OF ANTI-ICOS ANTIBODIES Application WO-2023222854-A1 World Intellectual Property Organisation (WIPO) 23 Nov 2023
Anti-CD25 for tumour specific cell depletion Grant US-11814434-B2 United States of America 14 Nov 2023
Anti-CD25 for tumour specific cell depletion Grant US-11802161-B2 United States of America 31 Oct 2023
Tolerogenic synthetic nanocarriers for allergy therapy Grant US-11779641-B2 United States of America 10 Oct 2023
Antibodies, combinations comprising antibodies, biomarkers, uses and methods Grant US-11779604-B2 United States of America 10 Oct 2023
Nucleic acids encoding anti-OX40L antibodies Grant US-11753479-B2 United States of America 12 Sep 2023
Anti-CD25 for tumour specific cell depletion Grant US-11697688-B2 United States of America 11 Jul 2023
Combination therapy using T cell redirection antigen binding molecule against cell having… Grant US-11660340-B2 United States of America 30 May 2023
Method for enhancing humoral immune response Grant US-11649293-B2 United States of America 16 May 2023
Anti-CTLA-4 antibodies and methods of use thereof Grant US-11638755-B2 United States of America 02 May 2023
Methods and compositions for attenuating anti-viral transfer vector immune responses Grant US-11633422-B2 United States of America 25 Apr 2023
Methods and compositions for enhancing the potency of superantigen mediated cancer… Grant US-11607452-B2 United States of America 21 Mar 2023
A COMBINATION OF, OR A BISPECIFIC BINDING MOLECULE TO, AN IMMUNE CHECKPOINT MOLECULE… Application US-20230042913-A1 United States of America 09 Feb 2023
USES OF ANTI-ICOS ANTIBODIES Application WO-2022243378-A1 World Intellectual Property Organisation (WIPO) 24 Nov 2022
MARKERS SELECTIVELY DEREGULATED IN TUMOR-INFILTRATING REGULATORY T CELLS Application EP-4092045-A1 European Patent Office 23 Nov 2022
T cell-redirected antigen-binding molecule for cells having immunosuppression function Grant US-11505605-B2 United States of America 22 Nov 2022
TIGIT antibodies, encoding nucleic acids and methods of using said antibodies in vivo Grant US-11440960-B2 United States of America 13 Sep 2022
Methods and compositions related to combined treatment with antiinflammatories and… Grant US-11426451-B2 United States of America 30 Aug 2022
THERAPEUTIC COMPOSITION AND METHOD COMBINING MULTIPLEX IMMUNOTHERAPY WITH CANCER VACCINE… Application WO-2022174064-A2 World Intellectual Property Organisation (WIPO) 18 Aug 2022
Anti-GITR antibodies and methods of use thereof Grant US-11401335-B2 United States of America 02 Aug 2022
AN LTBR AGONIST IN COMBINATION THERAPY AGAINST CANCER Application WO-2022117572-A3 World Intellectual Property Organisation (WIPO) 14 Jul 2022
Anti-OX40 antibodies and anti-GITR antibodies Grant US-11359028-B2 United States of America 14 Jun 2022
AN LTBR AGONIST IN COMBINATION THERAPY AGAINST CANCER Application WO-2022117572-A2 World Intellectual Property Organisation (WIPO) 09 Jun 2022
Anti-PD-1 antibodies and methods of use thereof Grant US-11345755-B2 United States of America 31 May 2022
Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising… Grant US-11298342-B2 United States of America 12 Apr 2022
Anti-CTLA-4 antibodies and methods of use thereof Grant US-11267889-B2 United States of America 08 Mar 2022
Methods for providing polymeric synthetic nanocarriers for generating antigen-specific… Grant US-11235057-B2 United States of America 01 Feb 2022
Methods and compositions for enhancing the potency of superantigen mediated cancer… Grant US-11202829-B2 United States of America 21 Dec 2021
ANTI-CCR8 ANTIBODIES FOR TREATING CANCER Application WO-2021194942-A1 World Intellectual Property Organisation (WIPO) 30 Sep 2021
Anti-CTLA-4 antibodies and methods of use thereof Grant US-11013802-B2 United States of America 25 May 2021
Anti-CTLA-4 antibodies and methods of use thereof Grant US-10912831-B1 United States of America 09 Feb 2021
MODULATION OF T CELL CYTOTOXICITY AND RELATED THERAPY Application WO-2021001567-A1 World Intellectual Property Organisation (WIPO) 07 Jan 2021
Anti-GITR antibodies and methods of use thereof Grant US-10829559-B2 United States of America 10 Nov 2020
Anti-GITR antibodies and methods of use thereof Grant US-10800849-B2 United States of America 13 Oct 2020
PHARMACEUTICAL COMPOSITION COMBINING IMMUNOLOGIC AND CHEMOTHERAPEUTIC METHOD FOR THE… Application WO-2020180686-A1 World Intellectual Property Organisation (WIPO) 10 Sep 2020
Anti-GITR antibodies and methods of use thereof Grant US-10577426-B2 United States of America 03 Mar 2020
Methods and compositions comprising a combination of a VEGF antagonist and an anti-CTLA-4… Application US-10532096-B2 United States of America 14 Jan 2020
Anti-CTLA-4 antibodies and methods of use thereof Grant US-10479833-B2 United States of America 19 Nov 2019
Anti-PD-1 antibodies and methods of use thereof Grant US-10450373-B2 United States of America 22 Oct 2019
ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS Application EP-3508215-A3 European Patent Office 02 Oct 2019
NOVEL COMBINATION AND USE OF ANTIBODIES Application WO-2019138005-A3 World Intellectual Property Organisation (WIPO) 19 Sep 2019
COMPOSITIONS COMPRISING A COMBINATION OF A VEGF ANTAGONIST AND AN ANTI-CTLA-4 ANTIBODY Application EP-3057990-B1 European Patent Office 04 Sep 2019
ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS Application EP-3508215-A2 European Patent Office 10 Jul 2019
ANTIBODIES TO ICOS Application WO-2019122884-A1 World Intellectual Property Organisation (WIPO) 27 Jun 2019
Anti-PD-1 antibodies and methods of use thereof Grant US-10323091-B2 United States of America 18 Jun 2019
Methods and compositions for enhancing the potency of superantigen mediated cancer… Grant US-10314910-B2 United States of America 11 Jun 2019
Anti-GITR antibodies and methods of use thereof Grant US-10280226-B2 United States of America 07 May 2019
Ipilimumab variant with enhanced ADCC Application US-10196445-B1 United States of America 05 Feb 2019
Anti-GITR antibodies and methods of use thereof Grant US-10155818-B2 United States of America 18 Dec 2018
Anti-CTLA-4 antibodies and methods of use thereof Grant US-10144779-B2 United States of America 04 Dec 2018
RECOMBINANT IMMUNOTOXINS FOR USE IN THE TREATMENT OF CANCER Application WO-2018064215-A1 World Intellectual Property Organisation (WIPO) 05 Apr 2018
ANTI-ICOS ANTIBODIES Application WO-2018029474-A2 World Intellectual Property Organisation (WIPO) 15 Feb 2018
ANTI-ICOS AND ANTI-PD-1 ANTIBODY COMBINATION THERAPY Application WO-2018025221-A1 World Intellectual Property Organisation (WIPO) 08 Feb 2018
CHIMERIC AND HUMANIZED ANTI-HUMAN CTLA4 MONOCLONAL ANTIBODIES AND USES THEREOF Application WO-2017106372-A1 World Intellectual Property Organisation (WIPO) 22 Jun 2017
ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS Application WO-2014089113-A1 World Intellectual Property Organisation (WIPO) 12 Jun 2014